Literature DB >> 1384665

Loss of heterozygosity for 10q loci in human gliomas.

B K Rasheed1, G N Fuller, A H Friedman, D D Bigner, S H Bigner.   

Abstract

Cytogenetic and RFLP studies have shown that chromosome 10 is frequently lost in tumor cells from glioblastomas, suggesting that a suppressor gene important in tumorigenesis is present on this chromosome. Forty-one tumors were examined for loss of heterozygosity at 23 loci on chromosome 10 to determine the smallest common deletion interval on this chromosome. Seven tumors did not lose heterozygosity for any of the markers. Twenty-three tumors lost an allele for all the informative loci. In 11 tumors heterozygosity was maintained at some loci and lost at other loci, indicating partial deletion of chromosome 10. The common region of deletion in these 11 tumors was located in 10q24-q26 between the markers pHUK-8 and pMCT122.2.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1384665     DOI: 10.1002/gcc.2870050111

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  29 in total

1.  Deletion mapping of gliomas suggest the presence of two small regions for candidate tumor-suppressor genes in a 17-cM interval on chromosome 10q.

Authors:  R Albarosa; B M Colombo; L Roz; I Magnani; B Pollo; N Cirenei; C Giani; A M Conti; S DiDonato; G Finocchiaro
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

2.  MiR-146b-5p suppresses EGFR expression and reduces in vitro migration and invasion of glioma.

Authors:  Mark Katakowski; Xuguang Zheng; Feng Jiang; Thomas Rogers; Alexandra Szalad; Michael Chopp
Journal:  Cancer Invest       Date:  2010-09-27       Impact factor: 2.176

3.  The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro.

Authors:  J T Winston; P Strack; P Beer-Romero; C Y Chu; S J Elledge; J W Harper
Journal:  Genes Dev       Date:  1999-02-01       Impact factor: 11.361

4.  Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth.

Authors:  Mark Katakowski; Ben Buller; Xuguang Zheng; Yong Lu; Thomas Rogers; Oyinkansola Osobamiro; Wayne Shu; Feng Jiang; Michael Chopp
Journal:  Cancer Lett       Date:  2013-02-16       Impact factor: 8.679

5.  Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas.

Authors:  F Yamaguchi; H Saya; J M Bruner; R S Morrison
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

Review 6.  Basic fibroblast growth factor and fibroblast growth factor receptor I are implicated in the growth of human astrocytomas.

Authors:  R S Morrison; F Yamaguchi; H Saya; J M Bruner; A M Yahanda; L A Donehower; M Berger
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

7.  Characterization of a new human glioblastoma cell line that expresses mutant p53 and lacks activation of the PDGF pathway.

Authors:  R A Gjerset; H Fakhrai; D L Shawler; S Turla; O Dorigo; A Grover-Bardwick; D Mercola; S F Wen; H Collins; H Lin
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-03       Impact factor: 2.416

Review 8.  Genetic alterations in glioma and medulloblastoma.

Authors:  B K Rasheed; S H Bigner
Journal:  Cancer Metastasis Rev       Date:  1991-12       Impact factor: 9.264

9.  Roles of BCCIP in chromosome stability and cytokinesis.

Authors:  X Meng; J Fan; Z Shen
Journal:  Oncogene       Date:  2007-04-23       Impact factor: 9.867

Review 10.  Molecular biology of pediatric gliomas.

Authors:  C Raffel
Journal:  J Neurooncol       Date:  1996 May-Jun       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.